
Results
2
2 companies
Starpharma Holdings
Market Cap: AU$282.2m
A biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications in Australia and internationally.
SPL
AU$0.67
7D
12.6%
1Y
652.8%
Clinuvel Pharmaceuticals
Market Cap: AU$447.3m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$8.93
7D
-2.4%
1Y
-15.4%